Meta Pixel

News and Announcements

Digital Engagement in COVID19 Environment Drives Demand for Lifecard Patient Portal

  • Published January 02, 2021 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Key Highlights:

  • Demand for Lifecard Patient Portal quadruples due to COVID19
  • Accelerated rollout expected to deliver $600K in recurring subscriptions over the next 18 months
  • Lifecard Patient Portal empowers consumers and doctors to better manage the healthcare process
  • Digital Engagement in healthcare is fast becoming the norm

Global Health Limited’s (ASX: GLH) (“Global Health”) Lifecard Patient Portal, is experiencing strong demand as Health Delivery Organisations across Australia embrace digital engagement with their patients.

Global Heath’s Lifecard Patient Portal was “soft-launched” over 36 months ago with deployments in three customer sites. Since the onset of COVID19 nine months ago, a further 12 portals have been commissioned. The current take-up extrapolates to a recurring revenue stream in excess of $50K per month within 18 months.

COVID19 has visibly accelerated demand, with Healthcare providers seeking accurate and current health information from patients to improve productivity, efficiency and overcome patient frustration of “telling their story” over and over again.

Re-keying patient information is a common source of error. Global Health’s Lifecard Patient Portal is embedded with industry-standard ReferralNet Secure Messaging which enables data collected on digital forms to seamlessly integrate directly with provider clinical systems thus eliminating any potential re-keying or transcription errors from the manual handling of patient data.

Patients complete their preadmission, registration and on-going assessment forms online. These are securely sent directly to their provider’s clinical application using the Government-approved Secure Messaging protocol. Patients can save their health information in their Lifecard Personal Health record and are thus empowered to pro-actively manage their healthcare.

Register Interest

Less paper time and more patient time

When patients create a Patient Portal account to complete their details, a Lifecard Health Record account is automatically created. Clinical and lifestyle information is stored within Lifecard which is particularly valuable for providers working with patients living with long-term conditions.

Key medical records, observations and measurements can be monitored and tracked within a patient’s Lifecard to encourage positive behaviour change. Lifecard’s current focus is helping people living with long-term conditions such as diabetes, asthma, or those consumers actively involved in sport, pregnancy or those over 60 years of age.

Global Health’s Managing Director Mathew Cherian said:

“Global Health is constantly looking to enhance the doctor/patient experience and improve healthcare provider productivity and efficiency, while ensuring that patients do not get lost in administration and paperwork when seeking help for their health conditions and medical issues.”

“The additional cost of the Lifecard Patient Portal will generate immediate financial returns for our Provider customers through time saved, reduced errors, and accurate patient health and financial information into Provider clinical systems. The bottom- line results are extremely compelling for healthcare providers.”

About Global Health Limited (ASX: GLH)

Global Health (ASX: GLH) is a leading provider of Digital Health solutions to the Australian Healthcare Industry. Innovation, consumer-centricity and connectivity are the foundations of the Company’s vision of ‘Connecting Clinicians and Consumers.’

Global Health applications helps streamline the delivery of healthcare services to provide better health outcomes. Our software is targeted at organisations that provide healthcare services to people living with chronic conditions such as Mental Health illness, Diabetes, and Cardiovascular disease.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now